
A recent study reveals a startling 79% increase in cancer cases among individuals under 50 globally over the past three decades, emphasizing the need for advanced cancer detection methods. Liquid biopsy, a non-invasive approach that analyzes circulating tumor cells and DNA in body fluids, is gaining momentum. It offers advantages over traditional tissue biopsy, including its ability to capture genetic material from multiple tumor locations, providing a holistic view of DNA mutations. Genomics-driven research company MedGenome lauds liquid biopsy's transformative potential, especially in cases where tissue biopsy isn't feasible. While promising, cost considerations must be addressed to make this approach widely accessible in countries like India.
Like
Save
Share